Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection

Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate...

Full description

Saved in:
Bibliographic Details
Published inEndocrine Connections Vol. 10; no. 6; pp. 646 - 655
Main Authors Vassiliadi, Dimitra Argyro, Ilias, Ioannis, Pratikaki, Maria, Jahaj, Edison, Vassiliou, Alice G, Detsika, Maria, Ampelakiotou, Kleio, Koulenti, Marina, Manolopoulos, Konstantinos N, Tsipilis, Stamatis, Gavrielatou, Evdokia, Diamantopoulos, Aristidis, Zacharis, Alexandros, Athanasiou, Nicolaos, Orfanos, Stylianos, Kotanidou, Anastasia, Tsagarakis, Stylianos, Dimopoulou, Ioanna
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 17.06.2021
Bioscientifica
Subjects
Online AccessGet full text
ISSN2049-3614
2049-3614
DOI10.1530/EC-21-0029

Cover

Loading…
Abstract Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Design Cohort observational study. Methods We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. Results A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. Conclusions NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients.
AbstractList Objective: Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, w e studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Design: Cohort observational study. Methods: We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. Results: A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of neg ative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. Conclusions: NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other crit ically ill patients.
Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Design Cohort observational study. Methods We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. Results A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. Conclusions NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients.
Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients. Cohort observational study. We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism. A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare. NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients.
Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients.OBJECTIVEFollowing the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests during illness, however, is hampered by changes occurring in the context of non-thyroidal illness syndrome (NTIS). In order to elucidate these findings, we studied thyroid function in carefully selected cohorts of COVID-19 positive and negative patients.Cohort observational study.DESIGNCohort observational study.We measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism.METHODSWe measured TSH, FT4, T3 within 24 h of admission in 196 patients without thyroid disease and/or confounding medications. In this study, 102 patients were SARS-CoV-2 positive; 41 admitted in the ICU, 46 in the ward and 15 outpatients. Controls consisted of 94 SARS-CoV-2 negative patients; 39 in the ICU and 55 in the ward. We designated the thyroid hormone patterns as consistent with NTIS, thyrotoxicosis and hypothyroidism.A NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare.RESULTSA NTIS pattern was encountered in 60% of ICU and 36% of ward patients, with similar frequencies between SARS-CoV-2 positive and negative patients (46.0% vs 46.8%, P = NS). A thyrotoxicosis pattern was observed in 14.6% SARS-CoV-2 ICU patients vs 7.7% in ICU negative (P = NS) and, overall in 8.8% of SARS-CoV-2 positive vs 7.4% of negative patients. In these patients, thyroglobulin levels were similar to those with normal thyroid function or NTIS. The hypothyroidism pattern was rare.NTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients.CONCLUSIONSNTIS pattern is common and relates to the severity of disease rather than SARS-CoV-2 infection. A thyrotoxicosis pattern is less frequently observed with similar frequency between patients with and without COVID-19. It is suggested that thyroid hormone monitoring in COVID-19 should not differ from other critically ill patients.
Author Zacharis, Alexandros
Orfanos, Stylianos
Diamantopoulos, Aristidis
Ampelakiotou, Kleio
Koulenti, Marina
Tsagarakis, Stylianos
Vassiliadi, Dimitra Argyro
Gavrielatou, Evdokia
Athanasiou, Nicolaos
Ilias, Ioannis
Pratikaki, Maria
Kotanidou, Anastasia
Jahaj, Edison
Vassiliou, Alice G
Detsika, Maria
Dimopoulou, Ioanna
Manolopoulos, Konstantinos N
Tsipilis, Stamatis
AuthorAffiliation Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
2nd Department of Critical Care Medical School National & Kapodistrian University of Athens Attikon University Hospital, Athens-Haidari, Greece
Department of Endocrinology Diabetes and Metabolism, Elena Venizelou Hospital, Elena Venizelou Square, Athens, Greece
Department of Immunology and Histocompatibility Evangelismos Hospital, Athens, Greece
1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
AuthorAffiliation_xml – name: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– name: 2nd Department of Critical Care Medical School National & Kapodistrian University of Athens Attikon University Hospital, Athens-Haidari, Greece
– name: Department of Immunology and Histocompatibility Evangelismos Hospital, Athens, Greece
– name: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
– name: Department of Endocrinology Diabetes and Metabolism, Elena Venizelou Hospital, Elena Venizelou Square, Athens, Greece
– name: 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
Author_xml – sequence: 1
  givenname: Dimitra Argyro
  surname: Vassiliadi
  fullname: Vassiliadi, Dimitra Argyro
  email: dimitra.vas@gmail.com
  organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
– sequence: 2
  givenname: Ioannis
  surname: Ilias
  fullname: Ilias, Ioannis
  organization: Department of Endocrinology Diabetes and Metabolism, Elena Venizelou Hospital, Elena Venizelou Square, Athens, Greece
– sequence: 3
  givenname: Maria
  surname: Pratikaki
  fullname: Pratikaki, Maria
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 4
  givenname: Edison
  surname: Jahaj
  fullname: Jahaj, Edison
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 5
  givenname: Alice G
  surname: Vassiliou
  fullname: Vassiliou, Alice G
  organization: 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 6
  givenname: Maria
  surname: Detsika
  fullname: Detsika, Maria
  organization: 1st Department of Critical Care, GP Livanos & M Simou Laboratories, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 7
  givenname: Kleio
  surname: Ampelakiotou
  fullname: Ampelakiotou, Kleio
  organization: Department of Immunology and Histocompatibility Evangelismos Hospital, Athens, Greece
– sequence: 8
  givenname: Marina
  surname: Koulenti
  fullname: Koulenti, Marina
  organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
– sequence: 9
  givenname: Konstantinos N
  surname: Manolopoulos
  fullname: Manolopoulos, Konstantinos N
  organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
– sequence: 10
  givenname: Stamatis
  surname: Tsipilis
  fullname: Tsipilis, Stamatis
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 11
  givenname: Evdokia
  surname: Gavrielatou
  fullname: Gavrielatou, Evdokia
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 12
  givenname: Aristidis
  surname: Diamantopoulos
  fullname: Diamantopoulos, Aristidis
  organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
– sequence: 13
  givenname: Alexandros
  surname: Zacharis
  fullname: Zacharis, Alexandros
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 14
  givenname: Nicolaos
  surname: Athanasiou
  fullname: Athanasiou, Nicolaos
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 15
  givenname: Stylianos
  surname: Orfanos
  fullname: Orfanos, Stylianos
  organization: 2nd Department of Critical Care Medical School National & Kapodistrian University of Athens Attikon University Hospital, Athens-Haidari, Greece
– sequence: 16
  givenname: Anastasia
  surname: Kotanidou
  fullname: Kotanidou, Anastasia
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
– sequence: 17
  givenname: Stylianos
  surname: Tsagarakis
  fullname: Tsagarakis, Stylianos
  organization: Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, Athens, Greece
– sequence: 18
  givenname: Ioanna
  surname: Dimopoulou
  fullname: Dimopoulou, Ioanna
  organization: 1st Department of Critical Care & Pulmonary Services, Medical School National & Kapodistrian, Evangelismos Hospital, University of Athens, Athens, Greece
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34010152$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFDEUhoNU7Ie98QdILkUYPckkM5MboQxrLRQEW70N-ZpuSnayJrOV_fdmulvZipibhJP3PG_Ce07R0RhHh9AbAh8Ir-Hjoq8oqQCoeIFOKDBR1Q1hRwfnY3Se8z2U1ZGmq-EVOq4ZECCcniBzu9ym6C1exrQqZKzC5JKafBwz9iM2yU_eqBC2WI0WF_PqoORDwOsiduOU8S8_LfHNxbebqo8_Klq6B2dm0Gv0clAhu_P9foa-f17c9l-q66-XV_3FdaVZx6eqIU1jGzuQgWttLAxEOaaVBdJYK0xnWhCWg9OEM8ZJp0HUbWupqEUNztn6DF3tuDaqe7lOfqXSVkbl5WMhpjupUnl6cHIAzVTLrWo7xxqnhSWDYrwjnHBlrSmsTzvWeqNXzpryw6TCM-jzm9Ev5V18kB1l0AIrgHd7QIo_Ny5PcuWzcSGo0cVNlpRTIWhTt7P07aHXH5OnlIoAdgKTYs7JDdL46TGjYu2DJCDnWZCLXlIi51koLe__anmi_lO852sfs5nT9ENJ-H8tvwGW-sS-
CitedBy_id crossref_primary_10_3390_ijerph19138063
crossref_primary_10_3389_fendo_2024_1411262
crossref_primary_10_3390_life12122014
crossref_primary_10_1007_s12020_023_03658_3
crossref_primary_10_3389_fendo_2022_1041676
crossref_primary_10_1038_s41574_023_00946_w
crossref_primary_10_3389_fendo_2022_1031188
crossref_primary_10_1007_s12020_022_03264_9
crossref_primary_10_3390_jpm12101703
crossref_primary_10_5812_ijem_146857
crossref_primary_10_3389_fendo_2024_1361479
crossref_primary_10_3389_fendo_2024_1477389
crossref_primary_10_1080_17446651_2022_2099372
crossref_primary_10_3389_fendo_2021_779692
crossref_primary_10_3389_fendo_2022_947594
crossref_primary_10_5662_wjm_v12_i3_99
crossref_primary_10_3390_ijerph19116912
crossref_primary_10_1186_s12917_024_04319_x
crossref_primary_10_3389_fendo_2022_840668
crossref_primary_10_1080_07435800_2021_1972307
ContentType Journal Article
Copyright The authors
The authors 2021 The authors
Copyright_xml – notice: The authors
– notice: The authors 2021 The authors
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1530/EC-21-0029
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate Thyroid function in SARS-CoV-2 infection
D A Vassiliadi et al
EISSN 2049-3614
EndPage 655
ExternalDocumentID oai_doaj_org_article_f0b4a75da78e46eb9d1fa4581515addc
PMC8240704
34010152
10_1530_EC_21_0029
Genre Journal Article
GroupedDBID 53G
5VS
AAFZV
ABLYK
ABSGY
ABSQV
ADACO
ADBBV
AIPOO
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
DIK
EBS
EE-
FRJ
GROUPED_DOAJ
GX1
INIJC
KQ8
M48
M~E
OK1
RHF
RPM
TBS
AAKMT
AAYXX
AOIJS
BTFSW
CITATION
F9R
H13
PGMZT
NPM
7X8
5PM
ID FETCH-LOGICAL-b485t-6166d6df1f5bbcd0f1ae4bad016dd9c8c709d50eb1544518b09377d293930eed3
IEDL.DBID M48
ISSN 2049-3614
IngestDate Wed Aug 27 01:24:59 EDT 2025
Thu Aug 21 13:46:15 EDT 2025
Fri Jul 11 01:49:32 EDT 2025
Thu Jan 02 22:56:04 EST 2025
Thu Apr 24 23:03:48 EDT 2025
Tue Jul 01 02:04:29 EDT 2025
Tue Jul 13 02:12:06 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords COVID-19
SARS-CoV-2
thyroid
critical illness
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b485t-6166d6df1f5bbcd0f1ae4bad016dd9c8c709d50eb1544518b09377d293930eed3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
D A Vassiliad and I Ilias contributed equally to this work
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1530/EC-21-0029
PMID 34010152
PQID 2529926374
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_f0b4a75da78e46eb9d1fa4581515addc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8240704
proquest_miscellaneous_2529926374
pubmed_primary_34010152
crossref_citationtrail_10_1530_EC_21_0029
crossref_primary_10_1530_EC_21_0029
bioscientifica_primary_10_1530_EC_21_0029
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-Jun-17
PublicationDateYYYYMMDD 2021-06-17
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-Jun-17
  day: 17
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bristol
PublicationTitle Endocrine Connections
PublicationTitleAlternate Endocr Connect
PublicationYear 2021
Publisher Bioscientifica Ltd
Bioscientifica
Publisher_xml – name: Bioscientifica Ltd
– name: Bioscientifica
SSID ssj0000816830
Score 2.2947106
Snippet Objective Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid...
Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid tests...
Objective: Following the evolution of COVID-19 pandemic, reports pointed on a high prevalence of thyroiditis-related thyrotoxicosis. Interpretation of thyroid...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
bioscientifica
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 646
SubjectTerms covid-19
critical illness
sars-cov-2
thyroid
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQTxyogEK7LSAjEFIPVh0_4uS4rLaqOPTQB-rNil_aSItTtdvD_nvGTna1QRVcuDpW4njGnu-zR98g9FU4LoM0nBhjgaDU1pMK7E4EN0lbJhQ-5GyLy_LiVvy4k3c7pb5STlgvD9xP3FmgRjRKukZVXpTe1K4IjZBVCsSwNm3afSHm7ZCpvAenchK50AgDCEw4BKFBm1RyejafEQYkmiZc-cq0vWpkTs0Zh6es4v8c9Pwzg3InJJ2_RvsDlsTT_h_eoBc-vkUH0wg8-tcaf8M5uzMfmx8ge7NYP3StwwsAqV30OF-T98d1uI3YDiUPlmvcRIdjF8lOU7tc4kGB9RGno1t8Pb26JrPuJ2F4k88V36Hb8_nN7IIMBRaIEZVcAW0sS1e6UIC1jHU0FI0XpnEAA52rbWUVrZ2ksJ1nHbPKUAAzygFCqDmF4Mrfoz0Yjz9COFgADsZB-AdCF5QxgYWSU-u8544rM0Gn44nW972ahk4sBIyi5zPNCp2MAn03NtB2UCpPBTOWz_b9su37tzd-T6bc9kia2rkBPE0Pnqb_5WkT9HnjCBrWYLpYaaLvnh41kxDUWcmVmKDD3jG2n-IiqfhJNkFq5DKjsYyfxHaRdb6rxLapOP4fgz9BL1nKxklVl9QHtLd6ePIfAU6tzKe8cn4DYlMfCg
  priority: 102
  providerName: Directory of Open Access Journals
Title Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection
URI http://dx.doi.org/10.1530/EC-21-0029
https://www.ncbi.nlm.nih.gov/pubmed/34010152
https://www.proquest.com/docview/2529926374
https://pubmed.ncbi.nlm.nih.gov/PMC8240704
https://doaj.org/article/f0b4a75da78e46eb9d1fa4581515addc
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELaWRUJ7AAHLozxWRiAkDmad2ImTA0Kl6rJCggO7Rb1Z8YtWCg60XYn-e8ZOUm1Q4ZJD4iRWZibzjTP5PoReccMylylGlNJQoJTakgLsTjhTgVvGJdbFbosv-fmMf5pn8wPU63d2D3C9t7QLelKzVf3296_tewj4d1G9h9HT6YSkUBPTtLyBbkJGEiFAP3cwP76Rg7hElB1JARATBimpYyodnn6EbjEeSNfCb0i31bKlk4w9O8O8Fen992HSv1srr-Wqs7voTgcy8bj1invowPr76HjsocD-scWvcWz7jOvpx0hfLrarZmnwAtBr4y2O38_bdTy89Fh3Wgj1FlfeYN94cm3Xsq5xR826xmFNF1-Mv16QSfONpLhv9PIP0Oxsejk5J53yAlG8yDZQT-a5yY1LwIxKG-qSynJVGcCHxpS60IKWJqPwno8EZ4WigHKEAehQMgpZlz1EhzAf-xhhpwFRKAO4ACo9J5RyqcsZ1cZaZphQI_Rm-KDlz5ZmQ4byBOwjpxOZJjLYB8b2NpC6ozAPShr13rEvd2P_d8UPwZS7EYFsO-5oVt9lF7vSUcUrkZlKFJbnVpUmcRXPioAFIT3oEXrRO4KE4AxfXCpvm6u1TDPI9mnOBB-hR61j7G7Ve9oIiYHLDOYyPOKXi0gAXoQynPIn_7zmU3SUht6boLEknqHDzerKPgfwtFEncdEBth_nyUmMkj8n6hhR
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thyroid+hormone+alterations+in+critically+and+non-critically+ill+patients+with+SARS-CoV-2+infection&rft.jtitle=Endocrine+Connections&rft.au=Vassiliadi%2C+Dimitra+Argyro&rft.au=Ilias%2C+Ioannis&rft.au=Pratikaki%2C+Maria&rft.au=Jahaj%2C+Edison&rft.date=2021-06-17&rft.issn=2049-3614&rft.eissn=2049-3614&rft.volume=10&rft.issue=6&rft.spage=646&rft_id=info:doi/10.1530%2FEC-21-0029&rft_id=info%3Apmid%2F34010152&rft.externalDocID=34010152
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2049-3614&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2049-3614&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2049-3614&client=summon